RIT Capital Partners plc - RCP.L

RCP.L Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
RCP.L	0.3	-0.5	2.4	8.0	7.4	9.2	-17.0	-3.8	39.6	1042.9
S&P 500	0.7	1.6	2.7	4.1	9.5	25.6	38.1	83.4	195.3	34394.1

Compare RCP.L with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	RCP.L
name	RIT Capital Partners plc
price	2000
changes percentage	0.3009
change	6
day low	1983.6599
day high	2005
year high	2030
year low	1698
market cap	2865620000
price avg 50	1953.08
price avg 200	1876.11
exchange	LSE
volume	279451
avg volume	249807
open	1996
previous close	1994
eps	1.62
pe	12.35
earnings announcement	2025-03-03T08:30:00.000+0000
shares outstanding	143281000
timestamp	2025-01-22 16:36:52

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 34.3%

Overall Quarterly Financial Health: 55.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	108800000	-533600000	120.39
gross profit	74900000	-534300000	114.02
gross profit ratio	0.69	1.0	-31.25
research and development expenses	0	-21.62	100.00
operating expenses	42700000	43600000	-2.06
interest income	17400000	9800000	77.55
interest expense	34400000	25000000	37.60
ebitda	100000000	-572300000	117.47
ebitdaratio	0.92	1.03	-11.17
operating income	100000000	-552500000	118.10
operating income ratio	0.92	1.04	-11.23
net income	66100000	-601900000	110.98
net income ratio	0.61	1.13	-46.14
eps	0.44	-3.87	111.37

Overall Score of Annual Income Statement

None

Detailed Analysis

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
revenue	86500000	86500000	0.00
gross profit	157700000	86500000	82.31
gross profit ratio	1.82	1	82.31
research and development expenses	0	0	NaN
operating expenses	8500000	8500000	0.00
interest income	0	7300000	-100.00
interest expense	0	0	NaN
ebitda	153000000	76575000	99.80
ebitdaratio	1.77	0.89	99.80
operating income	76500000	76500000	0.00
operating income ratio	0.88	0.88	0.00
net income	70700000	70700000	0.00
net income ratio	0.82	0.82	0.00
eps	0.97	0.49	97.96

Overall Score of Quarterly Income Statement

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 158 million in 2024Q2 from 86 million in 2024Q1 representing a change of 82.31%. This indicates a sales profitability growth, which is a positive sign for the company.

  Earnings per Share (EPS): EPS increased to 0.97 in 2024Q2 from 0.97 in 2024Q1 representing a change of 97.96%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 153 million in 2024Q2 from 77 million in 2024Q1 representing a change of 99.8%. The decrease in EBITDA indicates declined operational efficiency and profitability.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	3902100000	4171500000	-6.46
total liabilities	328800000	449800000	-26.90
total equity	3573300000	3721700000	-3.99
cash and cash equivalents	204300000	218000000	-6.28
short term investments	0	0	NaN
long term investments	3570700000	3644600000	-2.03
total current assets	341000000	375400000	-9.16
total non current assets	3632400000	3665300000	-0.90
total current liabilities	206400000	24100000	756.43
total non current liabilities	140900000	24100000	484.65
common stock	156800000	156800000	0.00
retained earnings	0	3519800000	-100.00
total debt	283700000	373800000	-24.10

Overall Score of Annual Balance Sheet

0.25 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 3,902 million in 2023 from 4,172 million in 2022 representing a change of -6.46%. Suggesting a decrease in asset holdings.

  Total Equity: Total Equity decreased to 3,573 million in 2023 from 3,722 million in 2022 representing a change of -3.99%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 204 million in 2023 from 218 million in 2022 representing a change of -6.28%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 341 million in 2023 from 375 million in 2022 representing a change of -9.16%. This indicates a worsen liquidity position.

  Total Current Liabilities: Total Current Liabilities increased to 206 million in 2023 from 24 million in 2022 representing a change of 756.43%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to 0 million in 2023 from 3,520 million in 2022 representing a change of -100.0%. This indicates an accumulated losses.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 329 million in 2023 from 450 million in 2022 representing a change of -26.9%. This indicates a decrease in overall liabilities.

  Total Debt: Total Debt decreased to 284 million in 2023 from 374 million in 2022 representing a change of -24.1%. This indicates a reduction in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
total assets	4030300000	4030300000	0.00
total liabilities	389400000	389400000	0.00
total equity	3640900000	3640900000	0.00
cash and cash equivalents	144300000	144300000	0.00
short term investments	0	0	NaN
long term investments	3626500000	3626500000	0.00
total current assets	338700000	338700000	0.00
total non current assets	3691600000	3691600000	0.00
total current liabilities	240600000	240600000	0.00
total non current liabilities	148800000	148800000	0.00
common stock	156800000	156800000	0.00
retained earnings	-38000000	3415800000	-101.11
total debt	284200000	284200000	0.00

Overall Score of Quarterly Balance Sheet

0.0 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Retained Earnings: Retained Earnings decreased to -38 million in 2024Q2 from 3,416 million in 2024Q1 representing a change of -101.11%. This indicates an accumulated losses.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-13700000	-107900000	87.30
operating cash flow	294200000	32700000	799.69
free cash flow	293900000	32600000	801.53
capital expenditure	-300000	-100000	-200.00
depreciation and amortization	300000	400000	-25.00
deferred income tax	-15000000	-20300000	26.11
stock based compensation	0	17600000	-100.00
accounts payables	0	-105300000	100.00
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	-300000	-100000	-200.00
net cash used for investing activites	-300000	-100000	-200.00
debt repayment	-81300000	-36200000	-124.59
common stock issued	0	0	NaN
common stock repurchased	-172900000	-51400000	-236.38
dividends paid	-56700000	-57600000	1.56
net cash used provided by financing activities	-310900000	-145200000	-114.12
cash at end of period	204300000	218000000	-6.28
accounts receivables	174100000	17500000	894.86
cash at beginning of period	218000000	325900000	-33.11

Overall Score of Annual Cashflow Statement

0.78 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -14 million in 2023 from -108 million in 2022 representing a change of 87.3%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 294 million in 2023 from 33 million in 2022 representing a change of 799.69%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 294 million in 2023 from 33 million in 2022 representing a change of 801.53%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to 0 million in 2023 from 0 million in 2022 representing a change of -200.0%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2023 from 18 million in 2022 representing a change of -100.0%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2023 from 105 million in 2022 representing a change of 100.0%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid increased to -57 million in 2023 from -58 million in 2022 representing a change of 1.56%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Deferred Income Tax: Deferred Income Tax increased to -15 million in 2023 from -20 million in 2022 representing a change of 26.11%. This indicates that the company's tax liability for future periods has increased.

  Accounts Receivables: Accounts Receivables increased to 174 in 2023 from 18 million in 2022 representing a change of 894.86%. This suggests that the company is less capable of collecting payments from its customers.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
operating cash flow	5600000	5600000	0.0
free cash flow	5600000	5600000	0.0
capital expenditure	0	0	NaN
depreciation and amortization	0	0	NaN
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	0	0	NaN
net cash used for investing activites	0	0	NaN
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	-22550000	-22550000	0.0
dividends paid	-14200000	-14200000	0.0
net cash used provided by financing activities	-35550000	-35550000	0.0
net change in cash	0	-30000000	100.0
cash at end of period	144300000	-30000000	581.0
cash at beginning of period	242100000	0	NaN

Overall Score of Quarterly Cashflow Statement

1.0 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 0 million in 2024Q2 from -30 million in 2024Q1 representing a change of 100.0%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	0.73	-3.43	121.20
net income per share	0.44	-3.87	111.42
operating cash flow per share	1.97	0.21	835.52
free cash flow per share	1.97	0.21	837.44
cash per share	1.37	1.4	-2.55
book value per share	23.9	23.94	-0.16
tangible book value per share	23.9	23.94	-0.16
shareholders equity per share	23.9	23.94	-0.16
interest debt per share	2.13	2.57	-17.06
market cap	2813590000	3303393462.5	-14.83
enterprise value	2892990000	3459193462.5	-16.37
pe ratio	42.57	-5.49	875.57
price to sales ratio	25.86	-6.19	517.72
pocfratio	9.56	101.02	-90.53
pfcf ratio	9.57	101.33	-90.55
pb ratio	0.79	0.89	-11.29
ptb ratio	0.79	0.89	-11.29
ev to sales	26.59	-6.48	510.17
enterprise value over ebitda	28.93	-6.04	578.63
ev to operating cash flow	9.83	105.79	-90.70
ev to free cash flow	9.84	106.11	-90.72
earnings yield	0.02	-0.18	112.89
free cash flow yield	0.1	0.01	958.48
debt to equity	0.08	0.1	-20.95
debt to assets	0.07	0.09	-18.86
net debt to ebitda	0.79	-0.27	391.66
current ratio	1.65	15.58	-89.39
interest coverage	2.91	-22.1	113.15
income quality	4.03	-0.06	7115.15
dividend yield	0.02	0.02	15.57
payout ratio	0.86	-0.1	996.36
sales general and administrative to revenue	0.08	-0.08	195.61
research and ddevelopement to revenue	0	0.0	-100.00
intangibles to total assets	0	0	NaN
capex to operating cash flow	0.0	0.0	-66.66
capex to revenue	0.0	-0.0	1571.32
capex to depreciation	1	0.25	300.00
stock based compensation to revenue	0	-0.03	100.00
graham number	15.42	45.67	-66.24
roic	0.03	-0.14	118.88
return on tangible assets	0.02	-0.14	111.74
graham net net	-0.7	-1.55	54.61
working capital	134600000	351300000	-61.69
tangible asset value	3573300000	3721700000	-3.99
net current asset value	12200000	-74400000	116.40
invested capital	156200000	372000000	-58.01
average receivables	90800000	137950000	-34.18
average payables	13400000	62000000	-78.39
average inventory	-126349999.5	-211400000	40.23
days sales outstanding	98.3	-104.18	194.35
days payables outstanding	29.07	12566.43	-99.77
days of inventory on hand	-59.22	-128897.14	99.95
receivables turnover	3.71	-3.5	205.99
payables turnover	12.56	0.03	43126.98
inventory turnover	-6.16	-0.0	-217564.46
roe	0.02	-0.16	111.44
capex per share	0.0	0.0	211.95

• Negative

  ROE: Return on Equity (ROE) increased to 0.02 on 2023-12-31 from -0.16 on 2022-12-31, representing a change of 111.44%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 42.57 on 2023-12-31 from -5.49 on 2022-12-31, representing a change of 875.57%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.08 on 2023-12-31 from 0.10 on 2022-12-31, representing a change of -20.95%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Neutral

  Current Ratio: Current Ratio decreased to 1.65 on 2023-12-31 from 15.58 on 2022-12-31, representing a change of -89.39%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Quarterly Financial Ratios

	2024-06-30 Q2	2024-03-31 Q1	Q/Q change %
RCP.L
calendar year	2024	2024	NaN
revenue per share	0.59	0.59	0.00
net income per share	0.49	0.49	0.00
operating cash flow per share	0.04	0.04	0.00
free cash flow per share	0.04	0.04	0.00
cash per share	0.99	0.99	0.00
book value per share	25.0	25.0	0.00
tangible book value per share	25.0	25.0	0.00
shareholders equity per share	25.0	25.0	0.00
interest debt per share	1.95	1.95	0.00
market cap	2650339855.8	2533841400.6	4.60
enterprise value	2790239855.8	2673741400.6	4.36
pe ratio	9.37	8.96	4.60
price to sales ratio	30.64	29.29	4.60
pocfratio	473.27	452.47	4.60
pfcf ratio	473.27	452.47	4.60
pb ratio	0.73	0.7	4.60
ptb ratio	0.73	0.7	4.60
ev to sales	32.26	30.91	4.36
enterprise value over ebitda	18.24	34.92	-47.77
ev to operating cash flow	498.26	477.45	4.36
ev to free cash flow	498.26	477.45	4.36
earnings yield	0.03	0.03	-4.40
free cash flow yield	0.0	0.0	-4.40
debt to equity	0.08	0.08	0.00
debt to assets	0.07	0.07	0.00
net debt to ebitda	0.91	1.83	-49.95
current ratio	1.41	1.41	0.00
interest coverage	0	0	NaN
income quality	0.08	0.08	0.00
dividend yield	0.01	0.01	-4.40
payout ratio	0.2	0.2	0.00
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0	0	NaN
capex to operating cash flow	0	0	NaN
capex to revenue	0	0	NaN
capex to depreciation	0	0	NaN
stock based compensation to revenue	0	0	NaN
graham number	16.53	16.53	0.00
roic	0.04	0.02	100.00
return on tangible assets	0.02	0.02	0.00
graham net net	-1.68	-1.68	0.00
working capital	98100000	98100000	0.00
tangible asset value	3640900000	3640900000	0.00
net current asset value	-50700000	-50700000	0.00
invested capital	119100000	119100000	0.00
average receivables	0	14650000	-100.00
average payables	0	1350000	-100.00
average inventory	0	0.5	-100.00
days sales outstanding	0	0	NaN
days payables outstanding	0	0	NaN
days of inventory on hand	0	0	NaN
receivables turnover	0	0	NaN
payables turnover	0	0	NaN
inventory turnover	0	0	NaN
roe	0.02	0.02	0.00
capex per share	0	0	NaN

• Negative

  ROE: Return on Equity (ROE) decreased to 0.02 on 2024-06-30 Q2 from 0.02 on 2024-03-31 Q1, representing a change of 0.00%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 9.37 on 2024-06-30 Q2 from 8.96 on 2024-03-31 Q1, representing a change of 4.60%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.08 on 2024-06-30 Q2 from 0.08 on 2024-03-31 Q1, representing a change of 0.00%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Neutral

  Current Ratio: Current Ratio decreased to 1.41 on 2024-06-30 Q2 from 1.41 on 2024-03-31 Q1, representing a change of 0.00%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 193.86 which is lower than current price 2000, indicates the company may be overvalued.